Impact of various central endoscopy reading models on treatment outcome in Crohn's disease using data from the randomized, controlled, exploratory cohort arm of the BERGAMOT trial.

Reinisch, Walter; Mishkin, Daniel S; Oh, Young S; Schreiber, Stefan; Hussain, Fez; Jacob, Rhian; Hassanali, Azra; Daperno, Marco

Reinisch, Walter; Mishkin, Daniel S; Oh, Young S; Schreiber, Stefan; Hussain, Fez; Jacob, Rhian; Hassanali, Azra; Daperno, Marco.

Afiliación

Reinisch W; Medical University of Vienna, Vienna, Austria.
Mishkin DS; Atrius Health, Boston, Massachusetts.
Oh YS; Genentech, Inc, South San Francisco, California, USA.
Schreiber S; Christian-Albrechts-University, Kiel, Germany.
Hussain F; Gastroenterology Center of Excellence, IQVIA, Reading.
Jacob R; Roche Products Limited, Welwyn Garden City, United Kingdom.
Hassanali A; Atrius Health, Boston, Massachusetts.
Daperno M; Mauriziano Hospital, Turin, Italy.

Gastrointest Endosc ; 93(1): 174-182.e2, 2021 01.

Article en En | MEDLINE | ID: mdl-32464142

Asunto(s)

Enfermedad de Crohn; Estudios de Cohortes; Enfermedad de Crohn/tratamiento farmacológico; Endoscopía; Humanos; Lectura; Resultado del Tratamiento

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Crohn Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Gastrointest Endosc Año: 2021 Tipo del documento: Article País de afiliación: Austria

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google